Recent Finacing
Recent Raise
Myricx is a UK biotech spinout from Imperial College London and the Francis Crick Institute developing N-myristoyltransferase inhibitors—as ADC payloads and small molecules—for oncology, establishing London/Stevenage R&D and labs.
